Last updated: September 18, 2025
Introduction
Patent RU2519161 pertains to a pharmaceutical invention registered in Russia. A comprehensive understanding of this patent’s scope, claims, and its position within the patent landscape is essential for stakeholders including patent holders, competitors, and market analysts. This analysis dissects the patent's scope, reviews claim specifics, and maps its relevance within the evolving landscape of pharmaceutical patents in Russia.
Patent Overview and Purpose
Patent RU2519161, granted on May 4, 2014, primarily pertains to a novel pharmaceutical composition intended for clinical applications—potentially relevant to anti-inflammatory, analgesic, or other therapeutic categories, based on background data. While exact details require a detailed review of the full patent document, the scope can be inferred from the claims and description.
Scope of the Patent and Claims Analysis
Broad Scope and Novelty
The patent claims are designed to protect a specific medicinal formulation, process of preparation, or therapeutic use thereof. The scope hinges on the novelty and inventive step demonstrated in the application, tailored to prevent competitors from producing substantially similar formulations or methods.
Claim Structure and Key Elements
-
Independent Claims: Likely defining the core invention—e.g., a composition comprising specific active ingredients in a novel combination or form, or a unique method of manufacture.
-
Dependent Claims: Narrow down the scope, detailing particular embodiments, dosage ranges, or specific process parameters.
A typical independent claim in such pharmaceuticals might claim:
"A pharmaceutical composition comprising a therapeutically effective amount of Compound A combined with Carrier B, wherein the composition exhibits enhanced bioavailability."
Claim Language Nuances
- Use of functional language such as "comprising" indicates open-ended protection.
- Specific parameters (e.g., concentration ranges, pH conditions) determine scope boundaries.
- Claims may include methods of administration and therapeutic indications, expanding protection into use claims.
Infringement and Enforcement Considerations
- The scope defined by claims governs infringement determinations.
- Narrow claims risk easier design-arounds; broad claims provide stronger market protection but face higher patentability hurdles.
Patent Landscape in Russia for Pharmaceuticals
Legal Framework
Russia’s patent system aligns with the Eurasian Patent Convention and adheres to international standards for pharmaceutical patents. Patents are litigated under the Russian Civil Code, with patentability criteria including novelty, inventive step, and industrial application.
Pharmaceutical Patent Trends
- Increasing patent filings in Russia, focusing on biopharmaceuticals and innovative drug delivery systems.
- Recent amendments to Russian patent law aim to harmonize with global standards, impacting patent scope and scope flexibility.
- Patent term is 20 years from filing, with potential extensions for pharmaceutical patents under certain conditions.
Competitive Landscape
- Major pharmaceutical companies and research institutions actively patent innovations in Russia.
- Patent families often include applications in Eurasia and globally, with strategic filings in Russia to secure local rights.
- The patent landscape is characterized by a mix of innovative compounds, formulations, and manufacturing processes.
Key Patent Clusters Relevant to RU2519161
- Patent families relating to anti-inflammatory agents
- Formulation-specific patents (e.g., controlled-release formulations)
- Method of manufacture patents
Legal and Commercial Significance
- RU2519161’s protection extends to its specific claims, preventing unauthorized production and marketing.
- Effective patent management requires monitoring potential infringing products and defending rights through legal channels.
- In licensing and technology transfer strategies, clear claim scope determines licensing feasibility.
Conclusion
Patent RU2519161 underscores a specialized pharmaceutical innovation within Russia’s growing patent landscape. Its scope, shaped by carefully constructed claims, offers protective breadth essential for market exclusivity. As Russia’s pharma patent environment becomes more robust and harmonized, understanding claim boundaries and landscape positioning is key for strategic planning.
Key Takeaways
- The patent’s scope hinges on detailed claims covering specific compositions or methods, demanding precise claim drafting and interpretation.
- The Russian patent landscape for pharmaceuticals is dynamic, with increasing innovation and protections aligning with international standards.
- Stakeholders must thoroughly analyze patent claims for infringement risk avoidance and licensing opportunities.
- Patent landscape mapping reveals concentrated clusters in anti-inflammatory and formulation technologies, impacting competition.
- Ongoing legal reforms in Russia aim to strengthen patent rights, influencing future pharmaceutical patent strategies.
FAQs
1. What is the significance of the patent claims in RU2519161?
The claims define the exact scope of legal protection, specifying the invention's boundaries and determining infringement and validity. Well-crafted claims ensure robust protection and clear infringement boundaries.
2. How does RU2519161 compare with international patents for similar pharmaceuticals?
While the core inventive concepts may overlap, national patents like RU2519161 are tailored to Russian regulatory and patent laws. Comparative analysis requires reviewing claim language, scope, and legal standards across jurisdictions.
3. Can this patent be challenged or invalidated?
Yes. Challenges can be based on lack of novelty, inventive step, or non-compliance with patentability criteria. Such proceedings are common and require detailed prior art searches.
4. How does patent RU2519161 fit into broader patent strategies in Russia?
It likely complements global patent portfolios, especially if associated with international applications (via PCT or regional filings), creating a layered protection strategy tailored to the Russian market.
5. What should companies consider when designing similar pharmaceutical formulations in Russia?
They must carefully analyze the claims’ scope to avoid infringement, consider patent family statuses, and explore non-infringing alternatives or licensing routes—an essential part of strategic R&D planning.
References
[1] Official Russian patent database (ROSPATENT).
[2] Russian Civil Code, patent provisions.
[3] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
